DekaBank Deutsche Girozentrale
NDRM

DekaBank Deutsche Girozentrale’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-9,200
Closed -$132K – 1105
2016
Q1 		$132K Buy
+9,200
New +$124K ﹤0.01% 915

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

DekaBank Deutsche Girozentrale's NDRM Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q2 2016, closing a stake of 9,200 shares — an estimated $132K sold.

DekaBank Deutsche Girozentrale first reported a position in NDRM in Q1 2016 and held it in 1 quarter. The position peaked at $132K in Q1 2016. 50 funds tracked by Wall St. Rank hold NDRM as of Q2 2016.

  • DekaBank Deutsche Girozentrale reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q2 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 9,200 NeuroDerm Ltd. Ordinary Shares shares in Q2 2016, an estimated $132K.
  • DekaBank Deutsche Girozentrale first reported a position in NeuroDerm Ltd. Ordinary Shares in Q1 2016 and held it in 1 quarter.
  • DekaBank Deutsche Girozentrale's NeuroDerm Ltd. Ordinary Shares position peaked at $132K in Q1 2016.
  • 50 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.